Title:
アクネの治療のためのGE2270因子A3のアミド誘導体の使用
Document Type and Number:
Japanese Patent JP4723857
Kind Code:
B2
Abstract:
Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl, Y represents the group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity against propionibacterium acne and are suitable for use in a method of treatment or prevention of acne.
Inventors:
Adriano Malabarba
Marco Cavaleri
Giorgio Mosconi
Daniela Yaves
Gabriella Romano
Marco Cavaleri
Giorgio Mosconi
Daniela Yaves
Gabriella Romano
Application Number:
JP2004512782A
Publication Date:
July 13, 2011
Filing Date:
June 06, 2003
Export Citation:
Assignee:
Viculon Pharmaceuticals, Inc.
International Classes:
A61K31/4545; C07D513/22; A61K8/00; A61K8/02; A61K8/06; A61K8/49; A61K38/12; A61K45/00; A61P17/10; A61Q19/00
Domestic Patent References:
| JP63287763A | ||||
| JP2000507248A | ||||
| JP3500767A |
Foreign References:
| US5599791 |
Other References:
PANZER J. D. et al,Acne Treatment: A Comparative Efficacy Trial of Clindamycin and Tetracycline,CUTIS,1977年 1月,vol.19, no.1,p.109-111
Attorney, Agent or Firm:
Mitsuo Tanaka
Masaki Yano
Masaki Yano